C12N 2740/16021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2740/16021 (Viruses as such) appears on 146 US grants and 96 published applications in this corpus.
Search patents in C12N- Granted patents
- 146
- Published applications
- 96
- Assignees
- 95
- Inventors
- 227
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 11 | 0 |
| 1999 | 10 | 0 |
| 2000 | 10 | 0 |
| 2001 | 11 | 1 |
| 2002 | 7 | 8 |
| 2003 | 13 | 17 |
| 2004 | 2 | 3 |
| 2005 | 6 | 6 |
| 2006 | 3 | 1 |
| 2007 | 3 | 4 |
| 2008 | 3 | 1 |
| 2009 | 4 | 1 |
| 2010 | 3 | 5 |
| 2011 | 1 | 2 |
| 2012 | 3 | 2 |
| 2013 | 3 | 3 |
| 2014 | 1 | 5 |
| 2015 | 1 | 2 |
| 2016 | 2 | 4 |
| 2017 | 2 | 4 |
| 2018 | 2 | 2 |
| 2019 | 4 | 7 |
| 2020 | 3 | 2 |
| 2021 | 3 | 4 |
| 2022 | 1 | 3 |
| 2023 | 3 | 4 |
| 2024 | 0 | 2 |
| 2025 | 3 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified HIV-1 proviral vectors with enhanced dendritic cell transduction efficiencies comprising the JRFL envelope23 Dec 2025US 12,503,499 B2University of Massachusetts
- Sindbis control virus24 Jun 2025US 12,338,463 B2LGC Clinical Diagnostics, Inc.
- Inducible CRISPR system expression and applications thereof14 Jan 2025US 12,195,750 B2The Florida International University Board of Trustees
- Recombinant HIV compositions and uses thereof in animal models27 Jun 2023US 11,684,666 B2University of Louisiana at Lafayette
- Inducible CRISPR system expression and applications thereof9 May 2023US 11,643,672 B2The Florida International University Board of Trusters
- Use of modified hiv-1 for generating fully human antibodies2 Jul 2026US 2026/0184767 A1University of Massachusetts
- Composition for treating hiv infection22 Jan 2026US 2026/0021133 A1National Institutes of Biomedical Innovation, Health and Nutrition
- Novel HIV-1 Variants And Their Methods Of Use In An Animal Challenge Model2 Oct 2025US 2025/0304923 A1Board of Regents, The University of Texas System
- Cas9 nickase-mediated gene editing15 Aug 2024US 2024/0271112 A1University of Massachusetts
- Methods and compositions for generating a deletion library and for identifying a defective interfering particle (dip)1 Feb 2024US 2024/0035021 A1The J. David Gladstone Institutes
Most cited
By later US patents
- Vector and method of use for nucleic acid delivery to non-dividing cells323US 6,013,516 AThe Salk Institute for Biological Studies · 2000
- Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor144US 4,708,818 AInstitut Pasteur · 1987
- Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes67US 4,839,288 AInstitut Pasteur · 1989
- Purified AIDS-associated virus ARV-244US 4,716,102 AThe Regents of the University of California · 1987
- Isolation of novel HIV-2 proviruses32US 5,883,081 AThe Regents of the University of California · 1999